Physician profile
Michael Aaron Parente
NPI 1699553545
$2,255.31
in general payments reported to CMS, 2019-2025
9 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,133 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,515 · Food and Beverage: $708 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,515.13 |
| Food and Beverage | $707.91 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,726.73 | 2024-2025 | Minimed 780g |
| Novo Nordisk INC | $238.89 | 2024 | Ozempic |
| Abbott Laboratories | $89.81 | 2024 | Freestyle Libre 3 |
| Beta Bionics, INC. | $60.94 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Lilly USA, LLC | $45.26 | 2024 | |
| Novartis Pharmaceuticals Corporation | $31.58 | 2024 | |
| Tandem Diabetes Care, INC. | $25.74 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $18.66 | 2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $17.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Parente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.